Topical Ocular Mecamylamine in Diabetic Macular Edema (DME)

PHASE2CompletedINTERVENTIONAL
Timeline

Start Date

September 30, 2007

Study Completion Date

April 30, 2008

Conditions
Diabetic Macular Edema
Interventions
DRUG

mecamylamine

topical ocular drops

Trial Locations (3)

21287

Johns Hopkins School of Medicine / Wilmer Eye Institute, Baltimore

94609

East Bay Retina Consultants, Inc., Oakland

02114

Ophthalmic Consultants of Boston, Boston

Sponsors
All Listed Sponsors
collaborator

Juvenile Diabetes Research Foundation

OTHER

lead

CoMentis

INDUSTRY